Moreover, PAK4 has been suggested to be closely related to the immune evasion of cancers [3,10], and it has been shown that the suppression of PAK4 enhances the anticancer therapeutic efficacy of immune checkpoint inhibitors [7,11]. Here, PAK4 is linked to cancer.